Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Condition(s):Breast Cancer; Brain MetastasesLast Updated:February 1, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Breast Cancer; Brain MetastasesLast Updated:February 1, 2024Recruiting
Condition(s):Estrogen Receptor-positive Breast Cancer; HER2-positive Breast CancerLast Updated:October 13, 2021Recruiting
Condition(s):Estrogen Receptor Positive Breast Cancer; Breast CancerLast Updated:January 30, 2024Recruiting
Condition(s):Breast CancerLast Updated:January 9, 2023Recruiting
Condition(s):Breast Cancer; Breast Neoplasms; Breast DiseasesLast Updated:March 28, 2024Not yet recruiting
Condition(s):Breast Cancer; Estrogen Receptor-positive Breast Cancer; HER2-negative Breast CancerLast Updated:September 6, 2023Recruiting
Condition(s):Breast Cancer; Triple Negative Breast CancerLast Updated:February 10, 2023Not yet recruiting
Condition(s):Breast CancerLast Updated:November 14, 2022Recruiting
Condition(s):Estrogen Receptor Positive Breast CancerLast Updated:April 25, 2023Recruiting
Condition(s):Breast CancerLast Updated:July 20, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.